8-12 Jan 2018, San Diego, CA
Presentation by Dr. Steven Chamow: Making Proteins “Druggable”: Fc Fusion Proteins as a Therapeutic Class
15-11 Dec 2016, San Diego, CA
Workshop with Dr. Steven Chamow: The Process of CMO Selection for Antibody Development: Matching Capabilities to Need
13-17 Jan, 2014, Palm Springs, CA
Speaker: Structural variation among antibody Fc-fusion proteins for human therapy.
19-22 Aug 2013, Boston, MA
Speaker: Challenges and tradeoffs in developing a scalable mAb process on a constrained budget: A case study.
29 Feb-2 Mar 2012, San Diego, CA
Speaker: Cellular synthesis of antibody fusion proteins. IBC 3rd Annual Recombinant Protein and Complex Biologics Development and Production.
15-18 May, 2011, Vienna, Austria
Workshop organizer and chair: Fc Fusion Proteins: A Growing Class of Therapeutics.
TIDES: Opgonucleotide and Peptide Technology and Product Development
18-21 May 2007, Las Vegas, NV
Speaker: Combining siRNA and nanoparticles: Tissue-selective and gene-targeted therapeutic candidates.
USP Annual Scientific Meeting
26-29 September 2006, Denver, CO
Speaker: Generic monoclonal antibody processes.
GAb 2004: International Symposium on Downstream Processing of Genetically Engineered Antibodies and Related Molecules
3-5 October 2004, Nice, France
Conference organizer and session chair: Antibody success stories.
IBC 10th International Conference on Antibody Production and Downstream Processing
25-27 February 2004, San Diego, CA.
Session chair: Enhancing expression productivity and increasing yields.
IBC 1st International Conference on Cell Culture and Upstream Processing
8-10 December 2003, San Diego, CA
Keynote address: What lies ahead for biologics production: Challenges in continuing to increase productivity.
June 2003, Tokyo, Japan
Speaker: Biopharmaceutical manufacturing: A critical challenge for biotechnology.
IBC Antibody Production
January 2003, Basel, Switzerland
Speaker: Rapid development of high concentration antibody formulations using an integrated experimental design.
International Symposium on Downstream Processing of Genetically Engineered Antibodies and Related Molecules
20-22 October 2002, Porto, Portugal
Conference organizer and session chair: Therapeutic antibodies of modified structure.
Antibody Production and Manufacturing
19-20 September 2002, Long Branch, NJ
Keynote address: A platform to rapidly produce human antibodies for clinical testing.
1st International Conference on Recombinant Antibodies and Innovations & Opportunities
16-17 May 2002, Berlin, Germany
Speaker: Transfection and homologous cell fusion of mammapan cells to produce recombinant antibodies.
IBC 8th International Conference on Antibody Production and Downstream Processing
13-15 February 2002, San Diego, CA
Keynote address: Options for antibody expression.
Waterside Monoclonal Conference
7-10 May 2001, Miami, FL
Speaker: Human antibodies: State of the art in antibody therapeutics.
IBC 7th International Conference on Antibody Production and Downstream Processing
31 Jan-2 Feb 2001, San Diego, CA
Session chair: Advances in expression systems and novel antibody forms.